Medby is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Solo founder Matthew Gallagher built Medby to $400M revenue (NYT verified) projecting $800M by prescribing Ozempic/Wegovy through telemedicine, keeping 100% ownership. Uses AI agents for marketing, operations, call center — 5% margin on $1B = $50M profit.